Market research firm Kalorama Information estimates the consumer market for genetic health testing could triple by 2022. 23andMe's Director of Product Science Shirley Wu explains how the testing company is differentiating itself in this growing market. "We are the only direct-to-consumer genetic testing company that provides health related information," said Wu. "We believe that everyone has the right to their own DNA information. It's information about you--you should know it if you want to know it." 23andMe CEO Anne Wojcicki has been outspoken about the company's efforts to maintain a gender-equal workforce. "It's been really great to be a part of a company like that where from the beginning we had really strong female leaders who set the vision for the company," says Wu. "There's never been a question of can women hold their own."

Share:
More In Technology
Tracking the Rapid Spread of the Omicron COVID-19 Variant
Six states have confirmed cases of the new Omicron coronavirus variant, and this number is expected to grow. Cheddar's Hena Doba speaks with Dr. William Schaffner, Professor of Preventive Medicine at Vanderbilt University Medical Center, on the latest developments.
Next Week on the Street: Earnings, Mosseri Testifies, Blue Origin Launch
Earnings season continues in the week of December 6 - 10, and that's only the start of a slate of events on the calendar that may move markets. We will also see executives from the crypto world and Instagram Head Adam Mosseri testify before members of Congress, and Square's name change to Block officially goes into effect.
Load More